Abstract

There is growing interest in the role and utilization of pulmonary artery catheters (PAC) in cardiogenic shock (CS). Observational evidence supports an association between PAC use and improved survival, and specialty societies increasingly advocate for its use. The PAC is useful for early diagnosis, decisions surrounding escalation of care, and daily management. Despite this, its use in Canada is variable. Registries and trials collecting prospective data mandate invasive hemodynamics, and forthcoming evidence-based treatment strategies are likely to be tailored to hemodynamic phenotypes. Herein we present the case for the routine use of PACs in the management of CS.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call